In line with previous editions, the Scientific Jury of the Charcot Fund 2020 is continuing with its choices to guarantee the excellence and continuity of MS research in Belgium. Its objective is to rapidly make MS a controllable neurological disease. The avenues being followed are: prevention, personalised treatment and the possibility of remyelination.

‍

The Jury’s choice this year therefore has focused on projects that work on a better understanding of the mechanisms of the disease, on projects that explore the role of macrophages and intercellular communication in remyelination and finally on two research projects involving revalidation processes. A budget of €500,000 has been allocated to 10 university teams. The successfull candidates received these grants at an academic session on 23 January at the University Foundation in Brussels.

Discover the laureates and the jury of the Charcot Fund 2020

Support here MS research

‍